Dermapharm (DMPHF) Q2 2026 Earnings

13MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
0.46
0.63
0.8
0.97

Details

Expected EPS
N/A
Actual EPS
0.9705108
Surprise EPS
0.97
Surprise Percent
+∞%

Description

Dermapharm (DMPHF) has reported earnings of 0.9705108 per share for Q2 2026.

0 Comments

Share your thoughts